MicroRNA-122 regulation of the morphology and cytoarchitecture of hepatoma carcinoma cells

被引:10
|
作者
Jin, Ji-Chun [1 ]
Zhang, Xian [1 ]
Jin, Xing-Lin [1 ]
Qian, Chang-Shi [1 ]
Jiang, Hao [1 ]
Ruan, Yang [1 ]
机构
[1] Yanbian Univ, Affiliated Hosp, Dept Hepatopancreatobiliary Surg, Yanji 133000, Jilin, Peoples R China
基金
中国国家自然科学基金;
关键词
Hep3B; hepatocellular carcinomas; cell morphology; microRNA-122; HEPATITIS-C VIRUS; GENE;
D O I
10.3892/mmr.2014.1930
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) are a large family of post-transcriptional regulators of gene expression that control a number of developmental and cellular processes in eukaryotic organisms and are ~23 nucleotides in length. miRNA-122 is an abundant liver-specific miRNA, implicated in fatty acid and cholesterol metabolism, as well as in hepatitis C viral replication and is frequently suppressed in primary hepatocellular carcinomas. In the current study, the Hep3B cell line with stable overexpression of miR-122 was successfully established through gene transfection methods and drug screening. miR-122 was observed to alter cell morphology in vitro by stable overexpression in Hep3B cells. This alteration was viewed by light microscopy and transmission electron microscopy. These alterations included increases in the cell volume, the appearance of lipid granules and vacuoles, thickening of nuclear membrane, swelling of the mitochondria, cytoplasm vacuolization and a more prominent nucleolus. Furthermore, the study provided novel evidence that miR-122 function was dependent upon its expression level. In addition, it was observed to negatively regulate mitochondria.
引用
收藏
页码:1376 / 1380
页数:5
相关论文
共 50 条
  • [1] Regulation of hepatitis C virus by microRNA-122
    Jopling, Catherine L.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2008, 36 : 1220 - 1223
  • [2] microRNA sponge blocks the tumor-suppressing functions of microRNA-122 in human hepatoma and osteosarcoma cells
    Ma, Ji
    Wu, Qi
    Zhang, Yue
    Li, Jinghua
    Yu, Yongchun
    Pan, Qiuhui
    Sun, Fenyong
    ONCOLOGY REPORTS, 2014, 32 (06) : 2744 - 2752
  • [3] Importance of circulating microRNA-122 for hepatocellular carcinoma
    Onan, Engin
    Akkiz, Hikmet
    Sandikci, Macit Umran
    Uskudar, Oguz
    BahadirOzturk, Agah
    CUKUROVA MEDICAL JOURNAL, 2021, 46 (03): : 1300 - 1308
  • [4] Antitumor function of microRNA-122 against hepatocellular carcinoma
    Kazuhiko Nakao
    Hisamitsu Miyaaki
    Tatsuki Ichikawa
    Journal of Gastroenterology, 2014, 49 : 589 - 593
  • [5] Regulation of the oncogenic function of distal-less 4 by microRNA-122 in hepatocellular carcinoma
    Xie, Xu-Hua
    Xu, Xiao-Pei
    Sun, Chang-Yu
    Yu, Zu-Jiang
    MOLECULAR MEDICINE REPORTS, 2015, 12 (01) : 1375 - 1380
  • [6] Expression Analysis of MicroRNA-21 and MicroRNA-122 in Hepatocellular Carcinoma
    Bharali, Dipu
    Banerjee, Basu D.
    Bharadwaj, Mausumi
    Husain, Syed A.
    Kar, Premashis
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 9 (03) : 294 - 301
  • [7] MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib
    Bai, Shoumei
    Nasser, Mohd W.
    Wang, Bo
    Hsu, Shu-Hao
    Datta, Jharna
    Kutay, Huban
    Yadav, Arti
    Nuovo, Gerard
    Kumar, Pawan
    Ghoshal, Kalpana
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (46) : 32015 - 32027
  • [8] Antitumor function of microRNA-122 against hepatocellular carcinoma
    Nakao, Kazuhiko
    Miyaaki, Hisamitsu
    Ichikawa, Tatsuki
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (04) : 589 - 593
  • [9] Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122
    Haldipur, Bangari
    Bhukya, Prudhvi Lal
    Arankalle, Vidya
    Lole, Kavita
    JOURNAL OF VIROLOGY, 2018, 92 (11)
  • [10] Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells
    He, Jialin
    Zhao, Kai
    Zheng, Lu
    Xu, Zhizhen
    Gong, Wei
    Chen, Shan
    Shen, Xiaodong
    Huang, Gang
    Gao, Min
    Zeng, Yijun
    Zhang, Yan
    He, Fengtian
    MOLECULAR CANCER, 2015, 14